CFO transition
CME Group Inc. CFO transition: Jack Tobin to succeed Lynne Fitzpatrick
CME Group Inc. reported in a Form 8-K filed September 9, 2026 that Jack Tobin will succeed Lynne Fitzpatrick as Senior Managing Director, Chief Financial Officer, effective March 2027.
In the filing's words
Mr. Tobin will assume the role of Chief Financial Officer in March 2027, effective with Lynne Fitzpatrick’s transition to the role of Chief Executive Officer, as detailed in the Company’s Current Report on Form 8-K filed on June 17, 2026. As the Senior Managing Director, Chief Financial Officer, Mr. Tobin will be a member of the Company’s Management Team.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | CME Group Inc. (CME) |
|---|---|
| Event | Transition |
| Incoming | Jack Tobin |
| Outgoing | Lynne Fitzpatrick |
| Title in the filing | Senior Managing Director, Chief Financial Officer |
| Effective | March 2027 |
| 8-K filed | September 9, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Managing Director and Chief Accounting Officer, CME Group Inc. |
| SEC CIK | 0001156375 |
CME Group Inc. reported this change in a Form 8-K, Item 5.02, filed September 9, 2026. The filing's own words are quoted above.
Other records naming Lynne Fitzpatrick
1The outgoing officer on this record, matched by name. Career line.
2026-02-26 · 10-K signature
Lynne Fitzpatrick signed CME Group's annual report as Senior Managing Director, President and Chief Financial Officer
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Jack Tobin? Send a correction with the primary source.